Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL.
Similar Posts
Government cuts red tape to revolutionise public services with cutting-edge tech
The government has announced it is slashing the red tape that holds back groundbreaking innovations from coming to market.
Guidance: Borderline products: medical devices and other products
How the MHRA makes decisions on whether a borderline product is a medical device and whether medical devices regulations should apply.
Clinical trials for medicines: apply for approval in the UK
How to apply for a clinical trial from 28 April 2026, including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Consultation on the International Council for Harmonisation (ICH) E21 Guideline on the Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials
The MHRA is consulting with UK stakeholders to gather feedback and comments on a new international guideline for the appropriate inclusion and/or retention of pregnant and/or breast-feeding individuals in clinical trials of medicines.
MHRA Safety Roundup: June 2025
Summary of the latest safety advice for medicines and medical device users
MHRA patient safety essay competition 2025
The MHRA is inviting the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.